Literature DB >> 389804

[Antibacterial activity of cefotaxim in comparison with seven cephalosporins].

I Braveny, H Dickert, K Machka.   

Abstract

The antibacterial activity of cefotaxim and seven cephalosporins was determined in 1,112 fresh isolates using the microdilution technique. All of the cephalosporins tested were ineffective against enterococci. Cefalotin was the most effective agent against Staphylococcus aureus. Cefaclor was superior to cephalexin against Escherichia coli and Proteus mirabilis, and thus inhibited 20% more Enterobacteriaceae. Cefazolin was as effective as cefamandole against E. coli. Cefuroxime and cefoxitin were almost equally effective against E. coli, Klebsiella and P. mirabilis; more than 95% of the strains were sensitive. Cefuroxime and also cefamandole were much more effective than cefoxitin against Citrobacter and Enterobacter. Cefoxitin on the other hand was superior against Serratia and indol-positive Proteus species. Cefotaxim was by far the most active cephalosporin against Enterobacteriaceae, only 2% of the strains being resistant. More than 90% of the strains of E. coli, Klebsiella, P. mirabilis and Serratia were sensitive to 1 mg/l, the lowest degree of activity being displayed against Enterobacter; 82% of the strains were inhibited by 16 mg/l. Cefotaxim was the only cephalosporin which showed appreciable activity against Pseudomonas.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389804     DOI: 10.1007/bf01648932

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

1.  Classification of cephalosporins by their antibacterial activity and pharmacokinetic properties.

Authors:  C H O'Callaghan
Journal:  J Antimicrob Chemother       Date:  1975       Impact factor: 5.790

2.  beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin.

Authors:  K P Fu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

3.  β-Lactamase Resistant Cephalosporins with Particular Reference to Cefuroxime.

Authors:  M H Richmond
Journal:  Proc R Soc Med       Date:  1977

4.  Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

5.  HR 756, a highly active cephalosporin: comparison with cefazolin and carbenicillin.

Authors:  R Wise; T Rollason; M Logan; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

6.  Comparison of the in vitro activities of HR756 with cephalothin, cefoxitin, and cefamandole.

Authors:  J P Sosna; P R Murray; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

7.  Cefaclor: in vitro spectrum of activity and beta-lactamase stability.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

8.  HR 756, a new cephalosporin active against gram-positive and gram-negative aerobic and anaerobic bacteria.

Authors:  H C Neu; N Aswapokee; P Aswapokee; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

9.  [In vitro testing of newer cephalosporins (author's transl)].

Authors:  G Linzenmeier; E Rosenthal
Journal:  Infection       Date:  1979       Impact factor: 3.553

  9 in total
  4 in total

1.  Effect of subinhibitory antibiotic concentrations on the phagocytosis of Staphylococcus aureus.

Authors:  D Milatović
Journal:  Eur J Clin Microbiol       Date:  1982-04       Impact factor: 3.267

2.  Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

3.  Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.

Authors:  I Braveny; K Machka; R Elsser
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

Review 4.  Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.